associate: dated: 21 august 2008 counsel for the applicant: bn caine sc and h rofe solicitor for the applicant: stephens lawyers &amp; consultants counsel for the second respondent: scg burley sc and nr murray solicitor for the respondents: clayton utz date of hearing: 28 july 2008 date of judgment: 21 august 2008 austlii: copyright policy | disclaimers | privacy policy | feedback url: http://www.austlii.edu.au/au/cases/cth/fca/2008/1283.html
the second cross claimant is the exclusive licensee of the patent in australia.
interpharma cannot apply for pbs listing of gemcitabine ebewe until it has obtained tga registration of gemcitabine ebewe.